Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ryan Specialty Holdings Inc. (RYAN:NYSE), powered by AI.
Ryan Specialty Holdings Inc. is currently trading at $35.44. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Ryan Specialty Holdings Inc. on Alpha Lenz.
Ryan Specialty Holdings Inc.'s P/E ratio is 71.1.
“Ryan Specialty Holdings Inc. trades at a P/E of 71.1 (premium valuation) with solid ROE of 9.9%. 3Y revenue CAGR of 20.9% highlights clear growth momentum.”
Ask for details →Ryan Specialty Holdings Inc. is a leading provider of specialty insurance solutions for brokers, agents, and consumers. It operates within the highly specialized niche of wholesale brokerage, underwriting, and other specialty services, primarily targeting the commercial insurance market. The company excels in offering tailored risk management solutions that cater to unique or emerging risks which standard insurance markets typically do not accommodate. Ryan Specialty Holdings serves various industries, including but not limited to construction, healthcare, technology, transportation, and energy sectors, offering a broad array of insurance products and advisory services. Recognized for its innovative approach, the company helps clients manage complex and sophisticated risk exposure efficiently. With its headquarters in Chicago, Illinois, Ryan Specialty Holdings has carved out a significant presence in both the U.S. and international markets, underscoring its role as a pivotal player in facilitating insurance market efficiency and diversification.
“Ryan Specialty Holdings Inc. trades at a P/E of 71.1 (premium valuation) with solid ROE of 9.9%. 3Y revenue CAGR of 20.9% highlights clear growth momentum.”
Ask for details →Ryan Specialty Holdings Inc. (ticker: RYAN) is a company listed on NYSE in the Financial Services sector (Insurance - Specialty). It has approximately 5,692 employees. Market cap is $4.5B.
The current price is $35.44 with a P/E ratio of 71.14x and P/B of 6.96x.
ROE is 9.94%. Annual revenue is $3.1B.